# Tergus Pharma LLC – FDA Inspection, Dec 13, 2024

Source: https://www.keypedia.com/records/fda_inspections/tergus-pharma-llc/7cabe855-70e8-48e9-ad13-b875424e6e77
Source feed: FDA_Inspections

> FDA inspection 1257890 of Tergus Pharma LLC, December 13, 2024. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257890
- Company Name: Tergus Pharma LLC
- Inspection Date: 2024-12-13
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1294372 - 2025-11-07](https://www.keypedia.com/records/fda_inspections/tergus-pharma-llc/7c402b5e-6481-44a8-8d02-31f2539e1a6d)
- FDA Inspection 1112674 - 2019-09-27
- [FDA Inspection 1048636 - 2016-10-07](https://www.keypedia.com/records/fda_inspections/tergus-pharma-llc/b1e09a51-7b9a-4290-95cf-6dfd633aff9b)
- FDA Inspection 947077 - 2015-10-09
- FDA Inspection 920748 - 2015-04-02

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/sri-rama-kr-yellela/b579e7ba-855b-4a15-b0fb-35bf33562d09)

Company: https://www.keypedia.com/companies/tergus-pharma-llc/430c8a0d-2cd5-47b6-91af-d5573fd6bda3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
